During the past decade, Blood and Marrow Transplant Group of Georgia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 12 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blood and Marrow Transplant Group of Georgia" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Northside Hospital, Inc." with 7 trials sponsored, "Pfizer" with 5 trials sponsored, "ADC Therapeutics S.A." with 3 trials sponsored and "Jazz Pharmaceuticals" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blood and Marrow Transplant Group of Georgia" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Blood and Marrow Transplant Group of Georgia" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Blood and Marrow Transplant Group of Georgia" are "Leukemia" (9 trials), "Lymphoma" (8 trials), "Acute Myeloid Leukemia" (7 trials), "Myelodysplastic Syndromes" (7 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Blood and Marrow Transplant Group of Georgia" in a lesser frequency.

Most popular intervention types in "Blood and Marrow Transplant Group of Georgia" are "Drug" (38 trials), "Biological" (10 trials), "Procedure" (9 trials), "Other" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "fludarabine phosphate" (7 trials), "tacrolimus" (6 trials), "cyclophosphamide" (5 trials), "methotrexate" (5 trials) and "cytarabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Blood and Marrow Transplant Group of Georgia" are 40 trials for "All" genders.

Currently, there are NaN active trials in "Blood and Marrow Transplant Group of Georgia". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Blood and Marrow Transplant Group of Georgia, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Blood and Marrow Transplant Group of Georgia, 12 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".